No abstract available
MeSH terms
-
Chronic Disease
-
Cost-Benefit Analysis
-
Hepatitis B / economics
-
Hepatitis B / therapy
-
Hepatitis C / economics
-
Hepatitis C / therapy
-
Humans
-
Interferons / economics*
-
Interferons / therapeutic use
-
Italy
-
Liver Diseases / economics*
-
Liver Diseases / therapy